Apellis Pharmaceuticals Inc. (APLS) - 13D/13G Filings

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Goto 0, 1, Next
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2026-04-07
08:06 am
Sale
2026-03-3113GAPELLIS PHARMACEUTICALS INC CO
APLS
WELLINGTON MANAGEMENT CO LLP249,635
0.200%
-13,500,912decrease
(-98.18%)
Filing
History
2026-04-06
6:08 pm
Purchase
2026-03-3113DAPELLIS PHARMACEUTICALS INC CO
APLS
BIOGEN IDEC INC.
BIIB
18,469,475
14.200%
18,469,475increase
(New Position)
Filing
History
2026-03-26
3:45 pm
Sale
2026-03-1313GAPELLIS PHARMACEUTICALS INC CO
APLS
VANGUARD GROUP INC0
0.000%
-9,555,678decrease
(Position Closed)
Filing
History
2026-02-17
08:25 am
Purchase
2025-12-3113GAPELLIS PHARMACEUTICALS INC CO
APLS
RTW INVESTMENTS LLC7,666,764
6.100%
7,666,764increase
(New Position)
Filing
History
2026-02-06
12:08 pm
Purchase
2026-01-3113GAPELLIS PHARMACEUTICALS INC CO
APLS
BlackRock Inc.
BLK
13,228,073
10.500%
7,629,501increase
(+136.28%)
Filing
History
2025-11-14
3:45 pm
Sale
2025-09-3013GAPELLIS PHARMACEUTICALS INC CO
APLS
EcoR1 Capital, LLC3,447,156
2.700%
-7,725,912decrease
(-69.15%)
Filing
History
2025-11-07
08:18 am
Purchase
2025-10-3113GAPELLIS PHARMACEUTICALS INC CO
APLS
WELLINGTON MANAGEMENT CO LLP13,750,547
10.900%
4,741,025increase
(+52.62%)
Filing
History
2025-08-12
10:34 am
Sale
2025-06-3013GAPELLIS PHARMACEUTICALS INC CO
APLS
WELLINGTON MANAGEMENT CO LLP9,009,522
7.200%
-2,823,887decrease
(-23.86%)
Filing
History
2025-05-16
4:42 pm
Purchase
2025-05-0913GAPELLIS PHARMACEUTICALS INC CO
APLS
Deep Track Capital, LP7,000,000
5.570%
1,000,000increase
(+16.67%)
Filing
History
2025-04-25
4:14 pm
Sale
2025-03-3113GAPELLIS PHARMACEUTICALS INC CO
APLS
BlackRock Inc.
BLK
5,598,572
4.500%
-593,365decrease
(-9.58%)
Filing
History
2025-02-10
10:49 am
Sale
2024-12-3113GAPELLIS PHARMACEUTICALS INC CO
APLS
WELLINGTON MANAGEMENT CO LLP11,833,409
9.500%
-3,766,120decrease
(-24.14%)
Filing
History
2025-02-03
1:09 pm
Purchase
2024-12-3113GAPELLIS PHARMACEUTICALS INC CO
APLS
MORGAN STANLEY
MS
9,592,751
7.700%
9,592,751increase
(New Position)
Filing
History
2024-11-22
4:16 pm
Sale
2024-11-2013GAPELLIS PHARMACEUTICALS INC CO
APLS
Deep Track Capital, LP6,000,000
4.820%
-220,265decrease
(-3.54%)
Filing
History
2024-11-22
08:47 am
Purchase
2024-11-1513GAPELLIS PHARMACEUTICALS INC CO
APLS
Deep Track Capital, LP6,220,265
5.000%
6,220,265increase
(New Position)
Filing
History
2024-11-14
1:28 pm
Sale
2024-09-3013GAPELLIS PHARMACEUTICALS INC CO
APLS
T. Rowe Price Investment Management, Inc.2,985,272
2.500%
-3,318,312decrease
(-52.64%)
Filing
History
2024-11-08
5:31 pm
Unchanged
2024-09-3013GAPELLIS PHARMACEUTICALS INC CO
APLS
BlackRock Inc.
BLK
6,191,937
5.100%
0
(Unchanged)
Filing
History
2024-11-08
10:52 am
Sale
2024-09-3013GAPELLIS PHARMACEUTICALS INC CO
APLS
WELLINGTON MANAGEMENT CO LLP15,599,529
12.810%
-878,321decrease
(-5.33%)
Filing
History
2024-10-18
3:31 pm
Purchase
2024-09-3013GAPELLIS PHARMACEUTICALS INC CO
APLS
BlackRock Inc.
BLK
6,191,937
5.100%
444,753increase
(+7.74%)
Filing
History
2024-02-14
5:18 pm
Purchase
2023-12-3113GAPELLIS PHARMACEUTICALS INC CO
APLS
EcoR1 Capital, LLC11,173,068
9.400%
4,865,521increase
(+77.14%)
Filing
History
2024-02-14
10:04 am
Purchase
2023-12-3113GAPELLIS PHARMACEUTICALS INC CO
APLS
T. Rowe Price Investment Management, Inc.6,303,584
5.300%
460,924increase
(+7.89%)
Filing
History
Goto 0, 1, Next